Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients

Transplant Infectious Disease

Volumn 11, Issue 5, 2009, Pages 405-412

  Shi, S H ^a   Kong, H S ^a   Xu, J ^a   Zhang, W J ^a   Jia, C K ^a   Wang, W L ^a   Shen, Y ^a   Zhang, M ^a   Zheng, S S ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bacteremia; Gram negative bacillus; Liver transplantation; Multidrug resistance; Risk factor

Indexed keywords

AZTREONAM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; GENTAMICIN; IMIPENEM; OKT 3; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; SULPERAZON; TACROLIMUS; TIMENTIN; TRIMETHOPRIM;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CATHETER INFECTION; COHORT ANALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROBACTERIACEAE; FEMALE; GRAFT RECIPIENT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEPATITIS; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTRAVASCULAR CATHETER; LIVER CIRRHOSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; OCHROBACTRUM ANTHROPI; PNEUMOCYSTIS JIROVECI INFECTION; PNEUMOCYSTIS JIROVECII INFECTION; PNEUMOCYSTOSIS; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; STENOTROPHOMONAS MALTOPHILIA; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS;

EID: 70349673008     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00421.x     Document Type: Article

References (31)

1. Candel FJ, Grima E, Matesanz M, et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005 37 : 4097 4099.
2. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004 10 : 844 849.
3. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001 7 : 22 26.
4. Gardiner DF, Scholand SJ, Babinchak T. Mortality and gram-negative rod bacteraemia in the intensive care unit. J Hosp Infect 2006 62 : 453 457.
5. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007 67 : 351 368.
6. Rupp ME, Fey PD. Extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003 63 : 353 365.
7. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: 12th Informational Supplement. M100-S12. Wayne, PA : NCCLS, 2002.
8. Shi SH, Lu AW, Shen Y, et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J 2008 121 : 625 630.
9. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986 6 : 97 106.
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988 16 : 128 140.
11. Saiman L, Mehar F, Niu WW, et al. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 1996 23 : 532 537.
12. Husni RN, Goldstein LS, Arroliga AC, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999 115 : 1378 1382.
13. Muder RR, Brennen C, Drenning SD, Stout JE, Wagener MM. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 1997 18 : 809 813.
14. McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med. 2006 119 (6 Suppl 1) : S29 S36.
15. Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. QJM 2003 96 : 227 234.
16. Hashimoto M, Sugawara Y, Tamura S, et al. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults. Transpl Infect Dis 2009 11 : 11 19.
17. Agodi A, Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med 2007 33 : 1155 1161.
18. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2002 132 : 391 402.
19. Bellier C, Bert F, Durand F, et al. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008 21 : 755 763.
20. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007 60 : 913 920.
21. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004 32 : 470 485.
22. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990 69 : 296 306.
23. Teo WY, Chan MY, Lam CM, Chong CY. Skin manifestation of Stenotrophomonas maltophilia infection - a case report and review article. Ann Acad Med Singapore 2006 35 : 897 900.
24. Daxboeck F, Zitta S, Assadian O, Krause R, Wenisch C, Kovarik J. Ochrobactrum anthropi bloodstream infection complicating hemodialysis. Am J Kidney Dis 2002 40 : E17 E22.
25. Moreno A, Cervera C, Gavalda J, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007 7 : 2579 2586.
26. Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003 37 : 214 220.
27. Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000 31 : 705 711.
28. Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol 2007 28 : 293 298.
29. Leroy O, d'Escrivan T, Devos P, Dubreuil L, Kipnis E, Georges H. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Infection 2005 33 : 129 135.
30. Paramythiotou E, Lucet JC, Timsit JF, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004 38 : 670 677.
31. Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998 129 : 182 189.